Cited by 262Genetic Associations and EpidemiologyDiabetes and associated disordersGenomics and Rare Diseases

Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population

Open access
Estrada, Karol, Aukrust, Ingvild, Bjørkhaug, Lise, Burtt, Noël P., Mercader, Josep M., García-Ortiz, Humberto, Huerta-Chagoya, Alicia, Moreno-Macías, Hortensia +42 more·2014·JAMA

Abstract

IMPORTANCE: Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES: To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS: Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14,276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES: Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS: A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% CI, 2.83-10.61; P = 4.4 × 10(-7)) in hepatocyte nuclear factor 1-α (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% CI, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE: Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2014.6511

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Estrada, K., Aukrust, I., Bjørkhaug, L., Burtt, N. P., Mercader, J. M., García-Ortiz, H., Huerta-Chagoya, A., Moreno-Macías, H., Walford, G., Flannick, J., Williams, A. L., Gómez-Vázquez, M. J., Fernandez-Lopez, J. C., Martínez-Hernández, A., Centeno-Cruz, F., Mendoza-Caamal, E., Revilla-Monsalve, C., Islas-Andrade, S., Córdova, E. J., Soberón, X., González-Villalpando, M. E., Henderson, E., Wilkens, L. R., Le Marchand, L., Arellano-Campos, O., Ordóñez-Sánchez, M. L., Rodríguez-Torres, M., Rodríguez-Guillén, R., Riba, L., Najmi, L. A., Jacobs, S. B. R., Fennell, T., Gabriel, S., Fontanillas, P., Hanis, C. L., Lehman, D. M., Jenkinson, C. P., Abboud, H. E., Bell, G. I., Cortes, M. L., Boehnke, M., González-Villalpando, C., Orozco, L., Haiman, C. A., Tusié-Luna, T., Aguilar-Salinas, C. A., Altshuler, D., Njølstad, P. R., Florez, J. C., & MacArthur, D. G.
Affiliations
  • Broad Institute (US)
  • University of Bergen (NO)
  • Haukeland University Hospital (NO)
  • Instituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico
  • Instituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico
  • Universidad Autónoma Metropolitana (MX)
  • Harvard University (US)
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
  • National Institute of Genomic Medicine (MX)
  • Unidad de Investigación Médica en Enfermedades Metabólicas, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City
  • Instituto Nacional de Salud Pública (MX)
  • University of Southern California (US)
  • University of Hawaii Cancer Center (US)
  • Epidemiology Program, University of Hawaii Cancer Center, Honolulu
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico
  • The University of Texas Health Science Center at Houston (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Chicago (US)
  • Broad Institute of Harvard and MIT, Cambridge, Massachusetts
  • University of Michigan (US)
  • Centro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Mexico City, Mexico
  • Instituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico17Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico
  • Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts3Department of Medicine, Harvard Medical School, Boston, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit),
Venue
JAMA
Published
2014-06-11
Volume
311
Issue
22
Pages
2305
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2055830789
Cited by
259
References
57
Citations by year
2026: 7 · 2025: 12 · 2024: 22 · 2023: 24 · 2022: 24 · 2021: 21 · 2020: 15 · 2019: 22 · 2018: 30 · 2017: 22 · 2016: 31 · 2015: 23 · 2014: 6
FWCI
17.95
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
Funders
  • Consejo Nacional de Ciencia y Tecnología
  • Helse Vest
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL024799, P01HL045522, R01HL24799)
  • National Cancer Institute (R35CA053890, CA164973, R01CA144034, R01CA080205, U01CA063464, R37CA054281, R35-CA53890, R01CA054281, R01 CA 80205, R01CA063464, UM1CA164973, CA054281, CA063464, R01CA055069, U01CA164973)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK085526, R01 DK057295, U01DK057295, U01DK085501, U01DK062370, R01DK042273, R01DK047482, R01DK053889, R01DK098032, R01DK033665, P30DK020572)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
type 2 diabetes, HNF1A, rare missense variants, Latino population, Mexican Americans, MODY3, genetic susceptibility, transactivation activity, age of onset, body mass index, exome sequencing, genetic association, diabetes prevalence, protein-coding variants, age at onset of diabetes
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 2, Female, Genotype, Hispanic or Latino, Humans, Male, Mexico, Middle Aged, United States, Sequence Analysis, DNA, Age of Onset, Mutation, Missense, Hepatocyte Nuclear Factor 1-alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review